India, July 1 -- image credit- freepik

In India, this segment of the life sciences industry is entering a period of significant transformation. Over the past decade, advances in molecular diagnostics, genomics, precision medicine, and biopharmaceutical development have driven substantial growth in demand for molecular biology reagents and enzymes. COVID-19 acted as a major catalyst for this shift, exposing the extent of India's dependence on imported enzymes and diagnostic components while highlighting the strategic importance of developing indigenous manufacturing capabilities.

India's molecular biology enzymes, reagents, and kits market is now recognised as one of the fastest-growing segments within the broader life sciences industry,...